Westwood Holdings Group’s Moderna MRNA Stock Holding History

Westwood Holdings Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Buy	+5,205	New	+$269K	﹤0.01%	526
2023 Q4	–	Sell	-9,067	Closed	-$937K	–	468
2023 Q3	$937K	Buy	9,067 +2,662	+42%	+$297K	0.01%	349
2023 Q2	$778K	Buy	6,405 +1,720	+37%	+$229K	0.01%	361
2023 Q1	$720K	Buy	+4,685	New	+$773K	0.01%	378
2022 Q4	–	Sell	-5,588	Closed	-$660K	–	586
2022 Q3	$660K	Sell	5,588 -327	-6%	-$49.6K	0.01%	349
2022 Q2	$844K	Buy	5,915 +1,454	+33%	+$208K	0.01%	357
2022 Q1	$769K	Sell	4,461 -1,334	-23%	-$225K	0.01%	372
2021 Q4	$1.47M	Buy	+5,795	New	+$1.69M	0.01%	321

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Westwood Holdings Group's MRNA Position: Q2 2026 in Review

Westwood Holdings Group opened a new position in Moderna (MRNA) in Q2 2026: 5,205 shares worth $365K. The stake represents ﹤0.01% of the portfolio and ranks #526 among its holdings. This is a return to the name: Westwood Holdings Group previously reported a position in MRNA as recently as Q3 2023.

Westwood Holdings Group first reported a position in MRNA in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.47M in Q4 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Westwood Holdings Group held 5,205 shares of Moderna worth $365K as of Q2 2026.
Moderna was a new Westwood Holdings Group position in Q2 2026.
Moderna made up ﹤0.01% of Westwood Holdings Group's portfolio in Q2 2026, its #526 holding.
Westwood Holdings Group first reported a position in Moderna in Q4 2021 and has held it in 8 quarters since.
Westwood Holdings Group's Moderna position peaked at $1.47M in Q4 2021.
783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Westwood Holdings Group's 13F filing for Q2 2026, filed 14 Aug 2026.